AssayIndex
Reports by quarter

Reports submitted in 2026-Q3 · page 9

Quarter in progress. Aggregates for this quarter are provisional. Median purity for the quarter is 98.93 % area, n=455. Read the 2026-Q3 state-of-the-index report →

455 records12 pagesmedian on this page 98.90 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042003SemaglutideAMBAMB-2607-N6274PeptideMeter2026-Q398.495.54—Buyer-sourced1MARGINAL
AX-2026-043291LiraglutideCPCCPC-2602-G9942VendorInvestigate2026-Q397.364.66—Buyer-sourced0FAIL
AX-2026-043183Kisspeptin-10GL BiochemGLBI-2608-N7715PeptideMeter2026-Q398.544.17102.2Buyer-sourced1MARGINAL
AX-2026-042267Humanin (HNG)TFCTFC-2605-U1300VendorInvestigate2026-Q399.166.8993.2Buyer-sourced0PASS
AX-2026-042126TB-500JEEPJEEP-2602-V8614Janoshik2026-Q399.932.82—Buyer-sourced0PASS
AX-2026-041911IpamorelinSinoPepSNP-2606-L4478Janoshik2026-Q399.165.17—Buyer-sourced0PASS
AX-2026-041323SemaglutideWWBWWB-2606-N3192Nordanalyt2026-Q399.144.3195.8Buyer-sourced0PASS
AX-2026-043482BPC-157BCHBCH-2603-L5474Janoshik2026-Q397.425.28—Buyer-sourced0FAIL
AX-2026-043432L-Glutathione (reduced)WXTWXT-2605-B3833Janoshik2026-Q397.526.08—Buyer-sourced0FAIL
AX-2026-042435IpamorelinHomopeptideHOMO-2608-A3930Janoshik2026-Q399.234.37102.9Buyer-sourced0PASS
AX-2026-043540GHRP-2SIGSIG-2603-6031PeptideMeter2026-Q398.601.36—Buyer-sourced1FAIL
AX-2026-042522SemaxHomopeptideHOMO-2605-S5227Nordanalyt2026-Q399.935.49—Buyer-sourced0PASS
AX-2026-043532GHRP-2SIGSIG-2603-6031PeptideMeter2026-Q399.241.24—Buyer-sourced0PASS
AX-2026-043372SemaglutideWXTWXT-2604-C3248PeptideMeter2026-Q396.694.2296.4Laboratory-retained1FAIL
AX-2026-043024AdipotideMKMMKM-2606-K5012Kestrel2026-Q398.615.07—Buyer-sourced0PASS
AX-2026-042520SemaxHomopeptideHOMO-2605-S5227Medutest2026-Q399.936.12—Buyer-sourced0PASS
AX-2026-042256TirzepatideTFCTFC-2605-G9870Janoshik2026-Q398.976.2689.2Buyer-sourced1MARGINAL
AX-2026-041434RetatrutideQYBQYB-2604-B4920Medutest2026-Q399.022.6596.9Laboratory-retained0PASS
AX-2026-041326SemaglutideWWBWWB-2606-N3192PeptideMeter2026-Q399.375.02—Buyer-sourced1FAIL
AX-2026-043476CJC-1295 with DACBCHBCH-2607-H5235Nordanalyt2026-Q397.835.39—Buyer-sourced1MARGINAL
AX-2026-043282TirzepatideCPCCPC-2607-L1516Janoshik2026-Q396.704.55—Buyer-sourced0FAIL
AX-2026-042498IGF-1 LR3HomopeptideHOMO-2607-P5131PeptideMeter2026-Q399.095.99105.0Buyer-sourced0PASS
AX-2026-043450BPC-157BCHBCH-2603-G4350PeptideMeter2026-Q398.304.0691.0Buyer-sourced1MARGINAL
AX-2026-041790RetatrutideASYASY-{CAT}-2288Nordanalyt2026-Q397.926.35—Buyer-sourced0PASS
AX-2026-041787RetatrutideASYASY-{CAT}-2288VendorInvestigate2026-Q398.896.29103.0Buyer-sourced0PASS
AX-2026-043371SemaglutideWXTWXT-2604-C3248Janoshik2026-Q397.164.3993.5Buyer-sourced1MARGINAL
AX-2026-042859SelankGGPepsGGPE-2603-J2447PeptideMeter2026-Q398.929.48103.5Buyer-sourced0FAIL
AX-2026-041923IGF-1 LR3SinoPepSNP-2606-D4620Janoshik2026-Q398.505.2994.5Buyer-sourced0PASS
AX-2026-042438RetatrutideHomopeptideHOMO-2605-V4718Nordanalyt2026-Q398.293.97—Buyer-sourced0PASS
AX-2026-042081MOTS-cHYBHYB-2606-D7858Nordanalyt2026-Q399.683.3196.5Laboratory-retained0PASS
AX-2026-041430RetatrutideQYBQYB-2604-B4920Kestrel2026-Q399.522.89—Buyer-sourced1FAIL
AX-2026-043598TesamorelinPPGPPG-2608-A6835Kestrel2026-Q398.912.56100.3Buyer-sourced1FAIL
AX-2026-043439BPC-157BCHBCH-2603-G4350PeptideMeter2026-Q399.034.26105.0Supplier-supplied2MARGINAL
AX-2026-042216SemaglutideTFCTFC-2604-X9037Janoshik2026-Q398.944.2593.1Buyer-sourced0PASS
AX-2026-041767ARA-290ASYASY-{CAT}-1521Janoshik2026-Q399.664.42103.7Buyer-sourced0PASS
AX-2026-041433RetatrutideQYBQYB-2604-B4920Janoshik2026-Q398.552.5797.1Buyer-sourced0PASS
AX-2026-041426RetatrutideQYBQYB-2604-B4920Janoshik2026-Q398.252.0491.7Buyer-sourced0PASS
AX-2026-043597TesamorelinPPGPPG-2608-A6835Janoshik2026-Q398.541.15—Buyer-sourced0PASS
AX-2026-043021AdipotideMKMMKM-2606-K5012VendorInvestigate2026-Q397.745.8396.9Buyer-sourced0PASS
AX-2026-042223SS-31 (Elamipretide)TFCTFC-2607-R9099Janoshik2026-Q399.445.15—Buyer-sourced0PASS